Published 2022-12-30
Keywords
- zspinal muscular atrophy,
- kinesic treatment,
- hypotonia,
- Onasemnogene Abeparvovec
- atrofia muscular espinal,
- tratamiento kinésico,
- hipotonía,
- Onasemnogene Abeparvovec
How to Cite
![Creative Commons License](http://i.creativecommons.org/l/by/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Abstract
Spinal muscular atrophy (SMA) is a hereditary, autosomal recessive neuromuscular disease. It causes progressive weakness and generalized muscle atrophy. Type I spinal muscular atrophy (Werdnig-Hoffmann disease) is the most severe form. This work offers a description of a four-month follow-up experience with a kinesic treatment in a patient suffering from this pathology. The patient was evaluated, and taking into account her clinical history, needs and restrictions, a kinesthetic treatment based on kinesitherapy and Kinefilaxia was developed and executed, also using tools to stimulate the cognitive- sensory area in coordination with her tutors. The results obtained from this experience were optimal, since the objectives previously set were met with the progress of the sessions, where the mínimum was a breakthrough.